Publication | Closed Access
Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers
13
Citations
11
References
2019
Year
Tolerance-based capecitabine dose escalation did not lead to more toxicity in DPYD variant carriers compared with wild-type patients. Our results can guide future prospective research.
| Year | Citations | |
|---|---|---|
Page 1
Page 1